Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti

BSE522.656.9 (+1.34 %)

PREV CLOSE ( ) 515.75

OPEN PRICE ( ) 518.35

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 27580

TODAY'S LOW / HIGH ( )507.90 527.00

52 WK LOW / HIGH ( )312.5 634.9

NSE523.205.4 (+1.04 %)

PREV CLOSE( ) 517.80

OPEN PRICE ( ) 520.20

BID PRICE (QTY) 523.20 (2)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 429155

TODAY'S LOW / HIGH( ) 507.05 529.80

52 WK LOW / HIGH ( )312 635

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-09 1984

Management Info

Prakash M Patil - Chairman Rashesh C Gogri - Managing Director

Registered Office

Address Plot No N 198,M I D C,Tarapur Village - Patembhi, Taluka Palghar,
Thane,
Maharashtra-401506

Phone 022-24019025

Email investorrelations@aartidrugs.com

Website www.aartidrugs.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

16Jul Clarification sought from Aarti Drugs
The Exchange has sought clarification from Aarti Drugs Ltd on July 16, 2..

07May Aarti Drugs informs about disclosure
In continuation to its intimation dated August 3, 2024 vide reference nu..

04Feb Aarti Drugs informs about acquisition
With reference to the query raised by BSE through email dated February 4..

30Jan Aarti Drugs gets nod to invest Rs 25 c
Aarti Drugs’ board has approved the investment in equity shares of Pinna..

30Jan Aarti Drugs climbs on getting nod to i
Aarti Drugs is currently trading at Rs. 406.65, up by 9.25 points or 2.3..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	486.399999999999	1573.1
Gross Profit	452.399999999999	1987.6
Operating Profit	643.299999999999	2762.3
Net Sales	5209.6	21736.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Blue Jet Healthcare (BSE) 1012.00 (4.21%)	M.Cap ( in Cr)17554.70
Jubilant Pharmova (BSE) 1234.90 (2.87%)	M.Cap ( in Cr)19669.63
Mercury Laboratories (BSE) 888.00 (3.71%)	M.Cap ( in Cr)106.56
Sanjivani Paranteral (BSE) 247.40 (11.39%)	M.Cap ( in Cr)303.91
Abbott India (BSE) 34148.85 (0.06%)	M.Cap ( in Cr)72563.92

Shareholding Pattern

	PROMOTERS	55.22%
	NON-INSTITUTION	32.58%
	MUTUAL FUNDS/UTI	9.85%
	FI/BANKS/INSURANCE	0.08%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
DSP Small Cap Fund-Reg(G)	1.71
DSP Healthcare Fund...	1.28
ICICI Pru Pharma He...	1.27
DSP Value Fund-Reg(G)	0.31
Motilal Oswal Nifty...	0.20
Bandhan BSE Healthc...	0.12
Motilal Oswal BSE H...	0.12

Risk Disclosures on Derivatives

Smart Quotes

AARTI DRUGS LTD.